Canada

Back to map

Showing 1-10 of 42 grants

Title Institution Researcher Program Duration Total Award Amount
Clinical Translation of Allarta’s Immune-Protective Hydrogel Encapsulation for Islet Transplantation in T1D Allarta Life Science Harald Stover Cures 15-June-2026 to 14-June-2029 $3,000,000.00
Translational Development of ILC210 Therapy for Islet Transplantation BC Cancer, part of Provincial Health Services Authority Sarah Crome Cures 01-October-2026 to 30-September-2029 $1,083,000.00
A combined chemical synthetic / intravital imaging approach to explore the survival and function of human pluripotent derived islets after transplantation in mice. Centre hospitalier de l’Universite de Montreal (CHUM) Guy Rutter Cures 01-April-2025 to 31-March-2027 $599,959.77
Development of an antigen-specific lipid nanoparticle mRNA therapy for T1D Integrated Nanotherapeutics, Inc Chris Tam Cures 01-June-2024 to 30-November-2026 $750,000.00
Safe and Immune Cloaked Stem Cell-Derived Beta-Cells: Treatment for Type 1 Diabetes Mellitus Sinai Health System Andras Nagy Cures 01-October-2022 to 30-September-2027 $1,474,390.51
Regenerating Human Pancreatic β Cells to Treat Diabetes Sunnybrook Research Institute Robert Screaton Cures 01-May-2022 to 31-May-2027 $900,000.00
Development of targeted nanoparticles for delivering therapeutics to islet cells for treatment of T1D The Governing Council of the University of Toronto Xiao Yu (Shirley) Wu Cures 01-April-2023 to 31-March-2027 $899,710.00
Synthetic vascularizing biomaterial platform for subcutaneous islet transplantation and immunomodulation The Governing Council of the University of Toronto Sean Kinney Cures 01-March-2025 to 29-February-2028 $237,690.00
Picosecond Infrared Laser (PIRL)-based spatial imaging mass spectrometry (proteomics) and transcriptomics of beta-cells in live human pancreas slices afflicted by T1D T-cell immune injury The Governing Council of the University of Toronto Herbert Gaisano Cures 01-April-2026 to 31-March-2027 $199,430.00
mRNA/LNP-based Epigenetic Immunomodulation to Restore Tolerance in T1D The Governing Council of the University of Toronto BOWEN LI Cures 01-April-2026 to 31-March-2027 $199,998.79